Molecular Pharming Market Overview
The Molecular Pharming Market is transforming biopharmaceutical production by using genetically modified plants, microorganisms, and animal cells as bio-factories for therapeutic proteins. Valued at USD 1.5 billion in 2024 and projected to reach USD 5.5 billion by 2035, this market is growing at a robust 12.8% CAGR. Molecular pharming offers sustainable, cost-effective alternatives to...
0 Comments 0 Shares 7 Views 0 Reviews